[Dr.Anisimova]

- текущая ситуация по лепре:
Current status of leprosy: Epidemiology, basic science and clinical perspectives
[Ссылки доступны только зарегистрированным пользователям ]

Topical permethrin and oral ivermectin in the management of scabies: A prospective, randomized, double blind, controlled study[Ссылки доступны только зарегистрированным пользователям ]
Conclusions: Both permethrin and ivermectin in both single and two dose regimen are equally efficacious and well tolerated in scabies. However, permethrin has a rapid onset of action.

Multiple lesions of granuloma annulare on the hand in a patient with scabies
[Ссылки доступны только зарегистрированным пользователям ]

Dermoscopic Features of Skin Lesions in Patients With Mastocytosis[Ссылки доступны только зарегистрированным пользователям ]

Reflectance Confocal Microscopic Features of Dermatophytes, Scabies, and Demodex
[Ссылки доступны только зарегистрированным пользователям ]
[Ссылки доступны только зарегистрированным пользователям ]

Dermatoscopy of facial actinic keratosis, intraepidermal carcinoma, and invasive squamous cell carcinoma: A progression model[Ссылки доступны только зарегистрированным пользователям ]

Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH)–a new autoinflammatory syndrome distinct from PAPA syndrome[Ссылки доступны только зарегистрированным пользователям ]
Conclusions
The clinical triad of pyoderma gangrenosum, acne, and suppurative hidradenitis represents a new disease entity within the spectrum of autoinflammatory syndromes, similar to PAPA and aseptic abscesses syndrome. For this disease, we propose the acronym “PASH” syndrome. PASH syndrome may respond to IL-1? blockade.

Infliximab Infusions for Netherton Syndrome: Sustained Clinical Improvement Correlates with a Reduction of Thymic Stromal Lymphopoietin Levels in the Skin
[Ссылки доступны только зарегистрированным пользователям ]

Neurocutaneous syndrome: A prospective study
[Ссылки доступны только зарегистрированным пользователям ]
Disorders classified as NCS include neurofibromatosis 1 (NF1), tuberous sclerosis (TS), Sturge-*Weber syndrome*More Details (SWS), von Hippel-Lindau (VHL) disease, PHACE syndrome, ataxia telangiectasia (AT), linear nevus syndrome (LNS), hypomelanosis of Ito (HOI), and incontinentia pigmenti (IP).

A clinical study of 125 patients with phrynoderma
[Ссылки доступны только зарегистрированным пользователям ]
Conclusion: Phrynoderma is a disorder with distinctive clinical features and can be considered as a multifactorial disease involving multiple nutrients, local factors like pressure and friction, and environmental factors in the setting of increased nutritional demand.
Phrynoderma, meaning toad skin, is a type of follicular keratosis coined and described by Nocholls in 1933. [1] Various nutritional deficiencies such as Vitamin (Vit) A, Vit B-complex, Vit E and Essential fatty acid (EFA) deficiency, as well as protein-calorie malnutrition have been suggested as possible etiological factors. However, the etiology of the disease is still controversial.
The disease was localized (elbows, knees, extensor extremities, and/or buttocks) in 106 (84.8%) patients and generalized (trunk and/or face) in 19 (15.2%) patients.

Wickham striae: Etiopathogenensis and clinical significance[Ссылки доступны только зарегистрированным пользователям ]

Electrical stimulation boosts therapeutic effect of PDT for keloid scar reduction
[Ссылки доступны только зарегистрированным пользователям ]
[Ссылки доступны только зарегистрированным пользователям ]

German–Austrian–Swiss Consensus Conference on clinical practice in chronic graft-versus-host disease (GVHD): guidance for supportive therapy of chronic cutaneous and musculoskeletal GVHD[Ссылки доступны только зарегистрированным пользователям ]
Supportive therapy plays a central role in the management of cutaneous and musculoskeletal manifestations of chronic graft-versus-host disease (cGVHD), either alone or in combination with systemic approaches.
What does this study add?
- We present results from the German–Austrian–Swiss Consensus Conference on clinical practice in cGVHD, held in Regensburg, Germany, in November 2009.
-тThe intention was to achieve a consensus on current evidence-based treatment options as well as to provide guidelines for daily clinical practice.